18 results
Pacemaker Coding Terminology
#Diagnosis #Cardiology #PPM #Pacemaker #LetterCode #Coding #Classification #Table #CoreEM
Pacemaker Coding ... Pacemaker #LetterCode #Coding ... #Classification ... #Table #CoreEM
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... medications to treat Type ... effects include GI ... it works in the GI ... #Pharmacology #Dosing
Hypokalemia - Differential Diagnosis
Poor Intake 
 - Starvation
 - Anorexia
GI Losses 
 - Vomiting / NG
- Anorexia GI ... tubular acidosis (Types ... and 2, but not type ... Low #Potassium #Table ... #Classification
Classification, Differential Diagnosis, and Features of Hyponatremia According to Volume Status 

Hypervolemic hypernatremia 
 - CHF
Classification, ... deficit - Salt-losing ... #Hyponatremia #Classification ... Differential #Diagnosis #Table
Hypersensitivity Types and Their Mechanisms
Type I - lgE - Soluble antigen
 - Allergen-specific lgE antibodies bind
Hypersensitivity Types ... Their Mechanisms Type ... or during hemolytic ... #Classification ... Diagnosis #Reactions #Table
The first three letters refer to chamber paced, chamber sensed, and response to sensed events. The
Pacemaker #LetterCode #Coding ... #Classification ... #Table
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
Hospital Quick Start Algorithm ... high-affinity, partial agonist ... If patient is stable ... Buprenorphine Dosing ... chronic pain split dosing
Irritable Bowel Syndrome (IBS) - Pathophysiology, Diagnosis and Management Algorithm
Risk factors: Previous acute enteric infection, Female
and Management Algorithm ... depression, Poor coping ... Tenapanor, 5-HT4 agonists ... Diagnosis #Management #Algorithm
Mild-to-Moderate Ulcerative Colitis - Management Algorithm
Curcumin:
 • Natural phytochemical from turmeric
 • 2g/day divided in 2-3
Colitis - Management Algorithm ... placebo • Potential GI ... with long-term dosing ... consider decreased dosing ... 5-ASA brands Algorithm
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
First Oral GLP-1 Agonist ... Dosing: 3 mg ... oral route by using ... drug to remain stable ... known to have GI